2018
DOI: 10.1016/j.bcp.2018.03.008
|View full text |Cite
|
Sign up to set email alerts
|

The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
45
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 58 publications
(48 citation statements)
references
References 90 publications
1
45
0
2
Order By: Relevance
“…ACE inhibitors (suppressing Angiotensin II synthesis) or Angiotensin Receptor Blockers (ARB’s, blocking AT1R signaling) can have a therapeutic potential in this context [81] . Basic and meta-analytic studies have shown that these drugs reduce the metastatic features of tumors [99] . Further studies are needed to assess the role of ACE-2 inhibitors in the prevention and treatment of SARS-CoV-2 infections.…”
Section: Potential Biomarkers To Identify High Risk Patients and Targmentioning
confidence: 99%
“…ACE inhibitors (suppressing Angiotensin II synthesis) or Angiotensin Receptor Blockers (ARB’s, blocking AT1R signaling) can have a therapeutic potential in this context [81] . Basic and meta-analytic studies have shown that these drugs reduce the metastatic features of tumors [99] . Further studies are needed to assess the role of ACE-2 inhibitors in the prevention and treatment of SARS-CoV-2 infections.…”
Section: Potential Biomarkers To Identify High Risk Patients and Targmentioning
confidence: 99%
“…A panel of GBM EC-enriched genes we identified are linked through the renin-angiotensin system (RAS): angiotensin I converting enzyme (ACE), glutamyl aminopeptidase (ENPEP) and NADPH oxidase 4 (NOX4). RAS inhibitors suppress progression and lengthen survival period in several cancer types (Ishikane and Takahashi-Yanaga, 2018; Pinter and Jain, 2017), including glioma (Levin et al, 2017), where they have a broad spectrum effectiveness, and are currently being considered for inclusion in treatment protocols (Perdomo-Pantoja et al, 2018). ACE and ENPEP are central enzymes in the RAS, catalysing the conversion of angiotensin I to angiotensin II, and angiotensin II to angiotensin III, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…The literature confirms changes in selected components of the RAS in different types of tumors, including OC. The mechanisms of tumorigenesis and cancer progression associated with these changes still remain unclear [ 89 , 90 , 91 ]. It has been described that the ACE2/Ang1-7/MAS1 cascade opposes the effects of the ACE1/Ang II/AT1 receptor axis, inhibiting cancer cell proliferation, reducing the migratory potential and invasiveness, limiting the formation of new blood vessels.…”
Section: Ovarian Diseases Related To the Ace2/ang-(1-7)/mas1 Axismentioning
confidence: 99%